QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 191 filers reported holding QIAGEN NV in Q4 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $717,522,000 | +26.6% | 26,061,695 | -0.5% | 0.38% | +23.0% |
| Q2 2016 | $566,914,000 | -2.4% | 26,190,642 | +0.5% | 0.30% | -1.0% |
| Q1 2016 | $580,982,000 | -18.1% | 26,064,755 | +0.3% | 0.31% | -14.2% |
| Q4 2015 | $709,137,000 | +3.2% | 25,982,163 | -2.6% | 0.36% | +5.9% |
| Q3 2015 | $687,046,000 | +7.9% | 26,684,778 | +2.9% | 0.34% | +17.3% |
| Q2 2015 | $636,848,000 | -3.4% | 25,929,013 | -0.7% | 0.29% | -3.3% |
| Q1 2015 | $659,041,000 | +12.7% | 26,114,878 | +4.7% | 0.30% | +12.8% |
| Q4 2014 | $584,578,000 | +11.2% | 24,953,574 | +8.0% | 0.26% | +10.4% |
| Q3 2014 | $525,902,000 | +37.5% | 23,096,063 | +46.4% | 0.24% | +42.0% |
| Q2 2014 | $382,522,000 | +47895.2% | 15,780,790 | +42321.5% | 0.17% | – |
| Q3 2013 | $797,000 | -2.6% | 37,200 | -9.7% | 0.00% | – |
| Q2 2013 | $818,000 | – | 41,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
| Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
| Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
| Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
| Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
| Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
| CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
| Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
| PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |